Font Size: a A A
Keyword [Hodgkin lymphoma]
Result: 41 - 60 | Page: 3 of 10
41. Variabilities Of Serum Proteomic Spectra In Patients With Non-hodgkin Lymphoma
42. Interaction Between HRS And Tumor-infiltrating CD4~+T Cells In CHL
43. NI Regimen For The Treatment Of Refractory And Relapsing Non-Hodgkin Lymphoma(NHL)
44. Survival Analysis Of Primary Gastric Non-Hodgkin Lymphoma
45. Clinical Study Of FND And CHOP Chemotherapy For Indolent Non-Hodgkin Lymphoma Patients
46. The Research On Expression Of Relative Immunomarkers In Neoplastic Cells And Background Cells Of Classical Hodgkin Lymphoma
47. The Expression Of Hyaluronan In Human Non-Hodgkin-Lymphoma And Its Effects On CEM Cell Proliferation And Invasiveness
48. Primary Thyroid Lymphoma: Clinical Study Of 12 Cases And Review Of The Literature
49. Management Of Adrenal Non-Hodgkin Lymphoma (Report Of 4 Cases)
50. Righting Cancer Side In Combination With Chop Regimen In The Treatment Of Non-hodgkin's Lymphoma Clinical Observation
51. Detection Of Bcl-2/IgH And IgH Rearrangements In Peripheral And Bone Marrow Lymphocytes Of The Patients With Non-Hodgkin Lymphoma
52. Expression And Clinical Significances Of Hedgehog Signaling Pathway In Non-Hodgkin's Lymphoma
53. The Effect Of Thalidomide On Serum VEGF In Patientswith Non-hodgkin Lymphoma And Their Clinical Significance
54. The Mechanisms Of CD99 Regulation On MiR-9/PRDM1 Inducing Redifferentiation Of H/RS Cells
55. Expression And Significance Of Circulating Endothelial Progenitor Cells In Non-Hodgkin Lymphoma
56. Genetic Variations Associated With Colorectal Cancer And Non-Hodgkin Lymphoma Susceptibility And Adverse Events In Rectal Cancer Patients Treated With Adjuvant Concurrent Chemoradiotherapy
57. Combating Non-hodgkin Lymphoma By Targeting Both CD20and HLA-DR Through CD20-243CrossMab
58. Clinical Studies Of Non-Hodgkins Lymphoma
59. Analysis Of Primary Extranodal Non-Hodgkin Lymphomas Of The Oral Cavity
60. 18F-FDG PET-CT Application In Lymphoma
  <<First  <Prev  Next>  Last>>  Jump to